Skip to main content
SpringerLink
Log in

Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Toll-like receptors (TLRs) are crucial for our host defense against microbial infections. TLR2 is especially important to fight bacterial infections, as it specifically recognizes bacterial lipoproteins of both Gram-positive and Gram-negative origin. Present on a variety of immune cells, TLR2 is critical for host protection against several bacterial infections, including those caused by Staphylococcus aureus. This major human pathogen causes increasing health care problems due to its increased resistance to antibiotics. S. aureus secretes a wide variety of proteins that inhibit innate immune responses. Recently, several staphylococcal superantigen-like proteins (SSLs) have been described to mediate immune evasive properties. Here, we describe that SSL3 specifically binds and inhibits TLR2 activation on human and murine neutrophils and monocytes. Through binding of the extracellular TLR2 domain, SSL3 inhibits IL-8 production by HEK cells expressing TLR1/2 and TLR2/6 dimers, stimulated with their specific ligands. The SSL3–TLR2 interaction is partially glycan dependent as binding of SSL3 to TLR2 is affected upon removal of sialic acid residues. Moreover, the SSL3(R308A) mutant lacking glycan-binding properties shows lower TLR2 inhibition. An SSL3 mutant, lacking the N-terminal 126 amino acids, still retains full TLR2 inhibiting activity. Of other SSLs tested, only SSL4, which shares the highest homology with SSL3, blocks TLR2 activation. SSL3 is the first-described bacterial protein that blocks TLR2 activation through direct extracellular interaction with the receptor. This unique function of SSL3 adds to the arsenal of immune evasive molecules that S. aureus can employ to subvert both innate and adaptive immunity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Arpaia N, Barton GM (2011) Toll-like receptors: key players in antiviral immunity. Curr Opin Virol 1:447–454

    Article  PubMed  CAS  Google Scholar 

  2. Bardoel BW, Strijp JA (2012) Molecular battle between host and bacterium: recognition in innate immunity. J Mol Recognit 24:1077–1086

    Article  Google Scholar 

  3. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373–384

    Article  PubMed  CAS  Google Scholar 

  4. Chang ZL (2010) Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res 59:791–808

    Article  PubMed  CAS  Google Scholar 

  5. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987–995

    Article  PubMed  CAS  Google Scholar 

  6. Krutzik SR, Sieling PA, Modlin RL (2001) The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol 13:104–108

    Article  PubMed  CAS  Google Scholar 

  7. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145

    Article  PubMed  CAS  Google Scholar 

  8. Zahringer U, Lindner B, Inamura S, Heine H, Alexander C (2008) TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205–224

    Article  PubMed  Google Scholar 

  9. Jin MS, Lee JO (2008) Structures of the toll-like receptor family and its ligand complexes. Immunity 29:182–191

    Article  PubMed  CAS  Google Scholar 

  10. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071–1082

    Article  PubMed  CAS  Google Scholar 

  11. Schenk M, Belisle JT, Modlin RL (2009) TLR2 looks at lipoproteins. Immunity 31:847–849

    Article  PubMed  CAS  Google Scholar 

  12. Archer KA, Roy CR (2006) MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect Immun 74:3325–3333

    Article  PubMed  CAS  Google Scholar 

  13. Dickinson GS, Piccone H, Sun G, Lien E, Gatto L, Alugupalli KR (2010) Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection. Infect Immun 78:4579–4588

    Article  PubMed  CAS  Google Scholar 

  14. Mancuso G, Midiri A, Beninati C, Biondo C, Galbo R, Akira S, Henneke P, Golenbock D, Teti G (2004) Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J Immunol 172:6324–6329

    PubMed  CAS  Google Scholar 

  15. Takeuchi O, Hoshino K, Akira S (2000) Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392–5396

    PubMed  CAS  Google Scholar 

  16. Stenzel W, Soltek S, Sanchez-Ruiz M, Akira S, Miletic H, Schluter D, Deckert M (2008) Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 172:132–145

    Article  PubMed  CAS  Google Scholar 

  17. Rooijakkers SH, van Kessel KP, van Strijp JA (2005) Staphylococcal innate immune evasion. Trends Microbiol 13:596–601

    Article  PubMed  CAS  Google Scholar 

  18. Lina G, Bohach GA, Nair SP, Hiramatsu K, Jouvin-Marche E, Mariuzza R (2004) Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 189:2334–2336

    Article  PubMed  Google Scholar 

  19. Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ (2007) Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 109:2936–2943

    PubMed  CAS  Google Scholar 

  20. Walenkamp AM, Bestebroer J, Boer IG, Kruizinga R, Verheul HM, van Strijp JA, de Haas CJ (2010) Staphylococcal SSL5 binding to human leukemia cells inhibits cell adhesion to endothelial cells and platelets. Cell Oncol 32:1–10

    PubMed  CAS  Google Scholar 

  21. Bestebroer J, van Kessel KP, Azouagh H, Walenkamp AM, Boer IG, Romijn RA, van Strijp JA, de Haas CJ (2009) Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood 113:328–337

    Article  PubMed  CAS  Google Scholar 

  22. de Haas CJ, Weeterings C, Vughs MM, de Groot PG, Van Strijp JA, Lisman T (2009) Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3. J Thromb Haemost 7:1867–1874

    Article  PubMed  Google Scholar 

  23. Itoh S, Hamada E, Kamoshida G, Takeshita K, Oku T, Tsuji T (2010) Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils. Infect Immun 78:3298–3305

    Article  PubMed  CAS  Google Scholar 

  24. Bestebroer J, Aerts PC, Rooijakkers SH, Pandey MK, Kohl J, van Strijp JA, de Haas CJ (2010) Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell Microbiol 12:1506–1516

    Article  PubMed  CAS  Google Scholar 

  25. Walenkamp AM, Boer IG, Bestebroer J, Rozeveld D, Timmer-Bosscha H, Hemrika W, van Strijp JA, de Haas CJ (2009) Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration. Neoplasia 11:333–344

    PubMed  CAS  Google Scholar 

  26. Itoh S, Hamada E, Kamoshida G, Yokoyama R, Takii T, Onozaki K, Tsuji T (2010) Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol Immunol 47:932–938

    Article  PubMed  CAS  Google Scholar 

  27. Patel D, Wines BD, Langley RJ, Fraser JD (2010) Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. J Immunol 184:6283–6292

    Article  PubMed  CAS  Google Scholar 

  28. Baker HM, Basu I, Chung MC, Caradoc-Davies T, Fraser JD, Baker EN (2007) Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J Mol Biol 374:1298–1308

    Article  PubMed  CAS  Google Scholar 

  29. Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD (2007) The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol 66:1342–1355

    Article  PubMed  CAS  Google Scholar 

  30. Bardoel BW, Hartsink D, Vughs MM, de Haas CJ, van Strijp JA, van Kessel KP (2012) Identification of an immunomodulating metalloprotease of Pseudomonas aeruginosa (IMPa). Cell Microbiol 14:902–913

    Article  PubMed  CAS  Google Scholar 

  31. Haas PJ, de Haas CJ, Kleibeuker W, Poppelier MJ, van Kessel KP, Kruijtzer JA, Liskamp RM, van Strijp JA (2004) N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J Immunol 173:5704–5711

    PubMed  CAS  Google Scholar 

  32. Bardoel BW, van der Ent S, Pel MJ, Tommassen J, Pieterse CM, van Kessel KP, van Strijp JA (2011) Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog 7:e1002206

    Article  PubMed  CAS  Google Scholar 

  33. Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH (2007) Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 204:2461–2471

    Article  PubMed  CAS  Google Scholar 

  34. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739

    Article  PubMed  CAS  Google Scholar 

  35. Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, Bhattacharyya A, Kaisho T, Kundu M, Basu J (2007) Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 8:610–618

    Article  PubMed  CAS  Google Scholar 

  36. Jimenez-Dalmaroni MJ, Xiao N, Corper AL, Verdino P, Ainge GD, Larsen DS, Painter GF, Rudd PM, Dwek RA, Hoebe K et al (2009) Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS One 4:e7411

    Article  PubMed  Google Scholar 

  37. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, Hennessy EJ, Ezekowitz RA, Moore KJ (2005) Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 170:477–485

    Article  PubMed  CAS  Google Scholar 

  38. Gerold G, Ajaj KA, Bienert M, Laws HJ, Zychlinsky A, de Diego JL (2008) A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin. Nat Immunol 9:761–768

    Article  PubMed  CAS  Google Scholar 

  39. Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R, Luppa PB, Ebel F, Busch DH, Bauer S et al (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113:1473–1481

    PubMed  CAS  Google Scholar 

  40. Weber AN, Morse MA, Gay NJ (2004) Four N-linked glycosylation sites in human toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion. J Biol Chem 279:34589–34594

    Article  PubMed  CAS  Google Scholar 

  41. Fraser JD, Proft T (2008) The bacterial superantigen and superantigen-like proteins. Immunol Rev 225:226–243

    Article  PubMed  CAS  Google Scholar 

  42. O'Neill LA, Bryant CE, Doyle SL (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 61:177–197

    Article  PubMed  Google Scholar 

  43. Benson MA, Lilo S, Wasserman GA, Thoendel M, Smith A, Horswill AR, Fraser J, Novick RP, Shopsin B, Torres VJ (2011) Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol 81:659–675

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

These studies were performed under the Immuno Valley ALTANT program funded by the Netherlands Ministry of Agriculture, Nature, and Food Quality and, later on, Netherlands Ministry of Economic Affairs, Agriculture, and Innovation. The authors thank Dr. Mark de Been for his help in constructing the phylogenetic trees.

Disclosure statement

None.

Author information

Authors and Affiliations

  1. Medical Microbiology, University Medical Center, Utrecht, The Netherlands

    B. W. Bardoel, R. Vos, T. Bouman, P. C. Aerts, J. Bestebroer, J. A. G. van Strijp & C. J. C. de Haas

  2. Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Berlin, Germany

    B. W. Bardoel

  3. Department of Chemistry, Faculty of Science, Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands

    E. G. Huizinga & T. H. C. Brondijk

Authors
  1. B. W. Bardoel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Vos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Bouman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. C. Aerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Bestebroer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. G. Huizinga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. H. C. Brondijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. A. G. van Strijp
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C. J. C. de Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. J. C. de Haas.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 301 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bardoel, B.W., Vos, R., Bouman, T. et al. Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med 90, 1109–1120 (2012). https://doi.org/10.1007/s00109-012-0926-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-012-0926-8

Keywords

Search

Navigation